PREDICTORS OF INTRAVESICAL TUMOR RECURRENCE FOLLOWING SELECTIVE BLADDER PRESERVATION IN MUSCLE-INVASIVE BLADDER CANCER PATIENTS

被引：0
|
作者：
Koga, Fumitaka
Fujii, Yasuhisa
Ishioka, Junichiro
Matsuoka, Yoh
Numao, Noboru
Saito, Kazutaka
Masuda, Hitoshi
Kawakami, Satoru
Kihara, Kazunori
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词：
D O I：
10.1016/j.juro.2013.02.2782
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1428
引用
收藏
页码：E585 / E585
页数：1
相关论文
共 50 条
  • [21] Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy
    Dunst, J
    Rödel, C
    Zietman, A
    Schrott, KM
    Sauer, R
    Shipley, WU
    SEMINARS IN SURGICAL ONCOLOGY, 2001, 20 (01): : 24 - 32
  • [22] Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer
    Rose, Tracy L.
    Deal, Allison M.
    Ladoire, Sylvain
    Crehange, Gilles
    Galsky, Matthew D.
    Rosenberg, Jonathan E.
    Bellmunt, Joaquim
    Wimalasingham, Akhila
    Wong, Yu-Ning
    Harshman, Lauren C.
    Chowdhury, Simon
    Niegisch, Guenter
    Liontos, Michalis
    Yu, Evan Y.
    Pal, Sumanta K.
    Chen, Ronald C.
    Wang, Andrew Z.
    Nielsen, Matthew E.
    Smith, Angela B.
    Milowsky, Matthew, I
    BLADDER CANCER, 2016, 2 (04) : 405 - 413
  • [23] Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer
    Miyamoto, David T.
    Mouw, Kent W.
    Feng, Felix Y.
    Shipley, William U.
    Efstathiou, Jason A.
    LANCET ONCOLOGY, 2018, 19 (12): : E683 - E695
  • [24] The role of biomarkers in bladder preservation management of muscle-invasive bladder cancer
    Timur Mitin
    Ananya Choudhury
    World Journal of Urology, 2019, 37 : 1767 - 1772
  • [25] Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder
    Michaelson, MD
    Shipley, WU
    Heney, NM
    Zietman, AL
    Kaufman, DS
    BRITISH JOURNAL OF CANCER, 2004, 90 (03) : 578 - 581
  • [26] Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder
    M D Michaelson
    W U Shipley
    N M Heney
    A L Zietman
    D S Kaufman
    British Journal of Cancer, 2004, 90 : 578 - 581
  • [27] Intravesical Gemcitabine Delivery System for muscle-invasive Bladder Cancer
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2023, 54 (06) : 433 - 433
  • [28] Tumor heterogeneity in muscle-invasive bladder cancer
    Kang, Ho Won
    Kim, Wun-Jae
    Choi, Woonyoung
    Yun, Seok Joong
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (06) : 2866 - 2880
  • [29] Organ preservation in muscle-invasive urothelial bladder cancer
    Niglio, Scot A.
    Purswani, Juhi M.
    Schiff, Peter B.
    Lischalk, Jonathan W.
    Huang, William C.
    Murray, Katie S.
    Apolo, Andrea B.
    CURRENT OPINION IN ONCOLOGY, 2024, 36 (03) : 155 - 163
  • [30] Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer
    Tsai, Henry K.
    Katz, Matthew S.
    Coen, John J.
    Zietman, Anthony L.
    Kaufman, Donald S.
    Shipley, William U.
    UROLOGY, 2006, 68 (06) : 1188 - 1192
12345